Aortic stenosis and aortic regurgitation express different titin isoforms: Differences and relationships with functional and geometric characteristics by Mannacio, Vito et al.
International Journal of Cardiology 259 (2018) 138–144
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdAortic stenosis and aortic regurgitation express different titin isoforms:
Differences and relationships with functional and
geometric characteristics☆Vito Mannacio a,⁎, Luigi Mannacio a, Anita Antignano b, Vincenzo De Amicis a,
Francesco Musumeci c, Gabriele Iannelli a
a Department of Cardiac Surgery, University Federico II, School of Medicine, Naples, Italy
b Department of Cardiology, Azienda Ospedaliera Santobono-Pausillipon, Naples, Italy
c Department of Cardiac Surgery, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy☆ All author takes responsibility for all aspects of the reli
the data presented and their discussed interpretation.
⁎ Corresponding author at: Via S. Domenico 62, 80127
E-mail address: vitoantonio.mannacio@unina.it (V. Ma
https://doi.org/10.1016/j.ijcard.2018.01.136
0167-5273/© 2018 Published by Elsevier B.V.a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 May 2017
Received in revised form 17 October 2017
Accepted 31 January 2018
Available online 2 February 2018Background-Titin represents an important biomechanical sensor which determines compliance and diastolic/
systolic function of the left ventricle (LV). To assess the different titin-isoform expression and the relationships
with functional and geometric patterns, we analyzed titin-isoform expression and cardiomyocytes contractile
function inmyocardial biopsy samples of patients undergoing aortic valve replacement (AVR) for aortic stenosis
(AS) and for aortic regurgitation (AR).
Method -Specimens, collected from the LV of 35with AS and 35with AR undergoing AVRwere analyzed for titin-
isoform expression and cardiomyocytes force measurement. Ten donor hearts were analyzed as controls for
normal values. Results were implemented with preoperative geometry and function assessed by Doppler
echocardiography.
Results-Compared to controls, N2BA/N2B titin-isoforms ratiowas reduced to 0.24 in AS (p b 0.001) but increased
to 0.51 in AR (p b 0.001). N2BA/N2B titin-isoforms ratio was further reduced in 8 patients with severe
(restrictive) diastolic dysfunction (0.17 ± 0.03, p b 0.001) but was increased in patients with severe systolic
dysfunction (0.58 ± 0.07, p b 0.001). As compared to controls, Fpasive was higher in AS (6.7 ± 0.2 vs 4.4 ±
0.4 kN/m2, p b 0.001) but was lower in AR (3.7± 0.2 vs 4.4 ± 0.4 kN/m2, p b 0.001). Total force was comparable.
Fpassive was signiﬁcantly higher in AS patients with severe than with moderate LV diastolic dysfunction (7.1 ±
0.5 vs 6.6. ± 0.6, p=0.004).
Conclusions-titin-isoform expression differs in AS and AR as adaptive response to different pathophysiologic
scenarios. Co-expressing isoforms at varying ratios results in modulation of the passive mechanical behavior of
the LV at different degree of dysfunction and allows for compensative adjustment of the diastolic/systolic
properties of the myocardium.
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Aortic stenosis (AS) and aortic regurgitation (AR) involve adaptive
processes which compensate for pressure or volume overload. These
processes are accompanied by structural remodeling substantiated by
derangements in the muscular and nonmuscular compartments of theability and freedom from bias of
Naples, Italy.
nnacio).left ventricle (LV). Cardiomyocytes develop distinct structural reshaping
of cytoskeletal, modiﬁcations in membrane-associated proteins and
reassembly of sarcomere components [1–3].
In the last years, several studies emphasized the role of titin within
the sarcomeres as the main determinant for the correct alignment of
actin and myosin myoﬁlaments and their elastic properties [4,5]. Titin
is expressed in two different isoforms, N2B and N2BA, with different
molecular and functional characteristics: the N2B isoform is stiffer and
less distensible, the longer N2BA isoform is more elastic and compliant
[6]. Together with the interstitial elastic and connective components,
titin isoform ratio determines not only the rigidity and the diastolic
properties of the ventricle, but also the systolic function modulating
the Frank-Starling mechanism [7].
Table 1
Clinical Proﬁle and Echocardiographic Left Ventricular Morphologic and Functional Characteristics of Patients.
Aortic stenosis
(n= 35)
Aortic regurgitation
(n.35)
Controls
(n= 10)
*p **p
Age (y) 61.5 ± 8.5 59.8 ± 9.3 38.7 ± 7.1 0.3 b0.001
Female sex 13(37.1%) 14(40%) 3(30%) 0.9 0.9
BMI (units of kg/m2) 23.6 ± 4.7 25.4 ± 5.1 25.3 ± 3.2 0.2 0.3
Hypertension 14(40%) 17(48.5%) 0.7
LV diastolic function
Mild dysfunction 2(6.6%)
Moderate dysfunction 25(71.4%) 2(6.6%)
Severe dysfunction 10(28.6)
LV systolic function
Normal 35(100%) 8(22.8%)
Mild dysfunction 14(40%)
Moderate Dysfunction 8(22.8%)
Severe dysfunction 5(14.4%)
LVEDVI (mL/m2) 68.3 ± 8.2 118.8 ± 28.5
LVESVI (mL/m2) 22.4 ± 3.1 54.2 ± 7.2
LVEF (%) 66.3 ± 5.4 44.7 ± 12.2
LVMI (g/m2) 144.3 ± 12.4 210.8 ± 21.5
RWT (%) 0.48 ± 0.04 0.35 ± 0.04
LVPWTd (mm) 11 ± 1.8 10 ± 1.7
IVSTd (mm) 13 ± 0.5 12 ± 0.3
LAI diameter (mm/cm2) 29 ± 2.4 25 ± 3.1
PASP (mm Hg) 61.5 ± 6.6 29.4 ± 7.6
AVAI (cm2/m2) 0.59 ± 0.05 1.8 ± 0.3
Peak velocity (m/s) 3.9 ± 0.03 2.1 ± 0.6
Mean pressure drop (mmHg) 42.8 ± 6.2 14.8 ± 2.2
Peak gradient (mm Hg) 105.5 ± 18.4 13.3 ± 3.1
Mean gradient (mm Hg) 55.5 ± 7.2 9.3 ± 2.1
Velocity ratio (m/s) 0.18 ± 0.03 0.9 ± 0.02
E/A ratio 1.7 ± 0.6 1.6 ± 0.7
E/E' ratio 13.3 ± 3.2 16.5 ± 2.1
Deceleration time (m/s) 167.8 ± 23.6 132 ± 18
S/D ratio 1.8 ± 0.09 0.8 ± 0.03
Diastolic ﬂow reversal Prominent olodiastolic
Pressure half time (m/s) 182 ± 24
Regurgitant jet/LVOT (width %ζ) 0.6 ± 0.05
Vena contracta (width cmζ) 0.6 ± 0.04
Regurgitant volume (mL/beat) 57.1 ± 4.5
Regurgitant fraction (%) 55.4 ± 5.1
Effective regurgitant oriﬁce (cm2) 27.5 ± 3.2
EFS% 27.8 ± 2.1 18.8 ± 2.2
MFS% 21.8 ± 2.1 12.8 ± 3.3
Values aremean± SD or numbers (percentage). BMI, Bodymass index. LV, Left Ventricle. *p, patients with aortic stenosis vs patients with aortic regurgitation. **p, control patients vs dis-
eased patients. LV systolic and diastolic dysfunction were graded according to the ESC or to the EAE/ASE recommendations respectively [21,23]. Hypertension was blood pressure above
140/90mmHg.
A: peak velocity during atrial systole; AVAI: aortic valve area index; D: diastolic peak velocity; E: early ﬂow velocity; E′: early diastolic velocity; EFS: endocardial fractional shortening;
IVSTd: interventricular-septum thickness in diastole; LAI: Left atrium index; LVEDVI: Left ventricular (LV) end diastolic volume index; LVEF: LV ejection fraction; LVESVI: LV end systolic
volume index; LVOT: LV outﬂow tract; LVMI: LV mass index; LVPWTd: LV posterior wall thickness in diastole; MFS: midwall fractional shortening; PASP: pulmonary artery systolic pres-
sure; RWT: relative wall thickness; S: systolic peak velocity.
ζ at a Nyquist limit of 50–60 cm.
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models [8,9]. However, paucity of data have been published regard-
ing human myocardium hitherto. Even the normal N2BA/N2B iso-
form ratio in normal human LV has not been deﬁnitively assessed
[10–12].
Some recent studies described alterations in titin isoform expres-
sion in the LV of patient with congestive heart failure secondary to is-
chemic disease, dilated cardiomyopathy or pressure overload
secondary to AS [10,13–15]. Actually, to date, no data are available
regarding the titin isoform behavior in patients with AR. Because of
insufﬁcient knowledge, the present study compared titin isoform ex-
pression and contractile function in the biopsy samples procured
from the LV of patients undergoing aortic valve replacement (AVR)
for pure AS or pure AR. Speciﬁc morphofunctional echocardiographic
characteristics were also analyzed for their possible relationship
with titin isoforms. A group of normal donor hearts were also ana-
lyzed as controls.2. Materials and method
2.1. Patients
Population consisted of 70 patients equally distributed between AS (n= 35) and
AR (n = 35) referred for primary isolated surgical AVR and operated on between
January 2011 and July 2016. According to ACC/AHA 2006 Guidelines, indications
for AVR in patients with AS were: area b1.0 cm2, mean gradient N40 mm Hg, jet ve-
locity N4.0 m/s in symptomatic patients or area b0.6 cm2, mean gradient N60 mm
Hg, jet velocity N5.0 m/s in asymptomatic patients. Indications for AVR in patients
with AR were: LV dysfunction (ejection fraction ≤0.50) in symptomatic or asymp-
tomatic patient and normal LV systolic function (ejection fraction N0.50) but severe
LV dilatation (end-diastolic dimension N75 mm or end-systolic dimension N55 mm)
in asymptomatic patients [16].
General exclusion criteria were: severe comorbidities (dialysis, hepatic failure), auto-
immune diseases (systemic lupus erythematosus, rheumatoid arthritis, scleroderma,
Sjögren's syndrome or psoriatic arthritis) or connective tissue disorders (Marfan syn-
drome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome), acute aortic dissection,
congenital defects of the aortic valve (bicuspid valve or sub-valvular stenosis induced by
ﬁxed or dynamic components), atrial ﬁbrillation, contemporary mitral and/or tricuspid
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considered as tolerable only a minimal and negligible presence of regurgitation in AS
patients or stenosis in ARpatients. To avoid signiﬁcant bias due to age-related titin expres-
sion, we included only patients no younger than 55 and not older that 65 years. All AS pa-
tients had echocardiography indicative of pressure overload, all AR patients had of volume
overload. Further exclusion criterion in patients with AS was reduced LV systolic function
(ejection fraction b0.50). All patients underwent preoperative conventional coronary
angiography or 64-Slice multidetector computed tomography [17].
Ten normal hearts obtained from donors for transplantation were analyzed as
reference values for normal titin distribution and force measurements. Body mass index
of controls patients was similar to that of diseased patients but age was signiﬁcantly low
(range 17 to 52 years, mean 38.7 ± 7.1). The cause of death was as follow: head trauma
(n=5), gunshot wound (n=2), intracranial hemorrhage (n=3). Controls had normal
cardiac dimensions, wall thickness, and ejection fraction. All donor hearts were implanted.
Main clinical and demographic characteristics of patients and controls are reported in
Table 1.
The study complies the declaration of Helsinki. The Institutional Research Ethics Com-
mittee approved this study and all patients provided written informed consent.
2.2. Echocardiographic measurements and calculations
All patients had comprehensive transthoracic echocardiography. When it was
assessed as poor or inadequate, the transoesophageal approach was employed. AS was
graded according to EAE/ASE recommendations [18]. AR was graded according to ASE
[19]. Reference limits of LV size, geometry and function were assessed according to ESC
recommendations [20]. Peak and mean aortic gradients were calculated from continuous
wave Doppler measurements using the modiﬁed Bernoulli equation and the aortic valve
area with the standard continuity equation. The LV functionwas evaluated by the ejection
fraction (LVEF) calculated by the Simpson rule. The LV mass was calculated from LV
linear dimensions by means of the ASE-recommended formula (LVmass = 0.8×(1.04
[(LVIDd+PWTd+SWTd)3-(LVIDd)3]) + 0.6 g) and normalized to body surface area
(LVMI). Calculation of relative wall thickness [RWT= 2xPWTd (Posterior Wall Thickness
in diastole)/LVIDd (LV internal diameter in Diastole)] permitted categorization of an in-
crease in LV mass as either concentric (≥0.42) or eccentric (≤0.42) hypertrophy. Patterns
of LV remodeling based on end diastolic volume, wall mass, and RWT were classiﬁed fol-
lowing the scheme proposed by Gaasch.21 Pulse wave tissue Doppler imaging was per-
formed in the apical views to acquire mitral annular velocities and support 2D images
for LV diastolic process.
Systolic and diastolic dysfunction of the LV were graded as mild, moderate or severe
[20,22].
2.3. Myocardial biopsies
All myocardial biopsies were taken as full-thickness specimens from the apex of the
left ventricle by means of an our patented device. Diseased hearts were sampled during
AVR before cannulation for cardiopulmonary bypass, donor hearts just before to be
explanted. In addition to the apex, the ﬁrst 3 donor hearts were also sampled from the
mid lateral wall to evaluate whether possible changes in the N2BA/N2B ratio from apex
to lateral wall might be a potential source of variability in results.
Biopsy products from patients and controls were handled carefully and divided into
samples of 5–8 mg each. Three to 4 were analyzed within 1 to 3 h for cardiomyocytes
force measurements, other were snap-frozen in liquid nitrogen. All samples were evalu-
ated blindly to patient identity or condition.
2.4. Titin isoform separation
For titin isoformmeasurement, tissue samples were homogenized in 100 to 200 μL of
Tris sodium dodecyl sulfate (SDS) buffer (pH 6.8) containing 8 g/mL leupeptin (Roche
Diagnostics, Monza, Italy) and 10mL phosphatase inhibitor cocktails DMSO solution, 10
μL/mL (Sigma-Aldrich, St Luis, MO, USA) and were heated (3min at 95–99 °C) and centri-
fuged (10 min, 13.000 g at 0 °C). Each sample was applied on agarose-strengthened 2%
SDS-polyacrylamide gels and stained with Coomassie brilliant blue R250. The optical vol-
ume of protein bands was determined with UN-SCAN-IT 6.1 densitometric software (Silk
Scientiﬁc, Orem, UT, USA). Titin isoform expression was determined as the proportion of
N2BA and N2B isoforms (N2BA+N2B= 100%). Titin degradation products were identi-
ﬁed as T2 band. Because multiple tissue samples were analyzed per heart, we ﬁrst evalu-
ated the individual mean isoform expression in each patient and then the “mean of
means” for group of patients.
Several randomly selected samples from the normal donor and from AS and AR
patients were rerun in order to assess the variability of the technique. Essentially the coef-
ﬁcient of variance was low (0.02–0.04).
2.5. Force measurements in isolated cardiomyocytes
Forcemeasurementswere performed in single,mechanically isolated cardiomyocytes
following the protocol described by Falcão- Pires et al. and according to our previous
study [13,14,23]. Biopsy samples were dissected into small strips in relaxing solution (inmmol/L: free Mg 1, KCl 100, ethylene glycol tetra-acetic acid 2, Mg-ATP 4, and imidazole
10; pH 7.0) and minced. To avoid titin degradation, solutions were supplemented with
40 μg/mL protease inhibitor leupeptin. To remove all membrane residuals, samples were
incubated for 5 min in relaxing solution supplemented with 0.2% Triton X-100. Under an
optical microscope, a singlemyocyte was suspended between a force transducer and a pi-
ezoelectric actuator. Single myocyte-sized preparations were carefully selected on the
basis of uniformity of the striation pattern. Force measurements were performed at a sar-
comere length of 2.2 μm and at 15 °C. Myocytes were subjected to relaxing and activating
solutions at various Ca2+ concentrations (pCa=−10log[Ca2+]). Starting from pCa 9.0 m
(maximal relaxation), exposed to a series of solutionswith intermediate pCa,maximal ac-
tivation was obtained at pCa 4.5. The maximal activation was used to calculate maximal
calcium-activated isometric force (Fmax). From the resulting force-pCa curve, the Ca2+
concentration generating 50% of maximal force (pCa50) was determined using sigmoid
regression analysis (SigmaPlot). Fig. 2-a. Once a steady state force level was reached, the
length of the myocyte was reduced by 20% within 2 ms using the piezoelectric motor
(slack test). The distance between the baseline and the steady force level was the total
force (Ftotal). The cell was than restretched and returned to the relaxing solution, in
which a second slack test of 10-s duration was performed to determine passive force
(Fpassive). Maximal calcium activated tension (Factive) was calculated by subtracting
Fpassive from the Ftotal at saturating [Ca2+] (pCa 4.5). To assess the behavior of Fpassive,
following the baseline force-pCa measurements, cardiomyocytes were incubated for 40
min at 22° in relaxing solution supplemented with the catalytic subunit from bovine
heart of protein kinase A (PKA, 100 U/mL; Merck S.p.a., Milan, Italy) and 6mmol/L dithio-
threitol (Merck S.p.a., Milan, Italy).
2.6. Statistics
Values are given as percentages or mean ± SD. The normal distribution of the
continuous values was tested by means of the Anderson-Darling test. A p value
N0.05 was considered indicative of normal distribution. One-way Analysis of Variance
(ANOVA) was performed among AS, AR and control groups to compare continuous
variables normally distributed (age, N2BA/N2B isoform ratio, Ftotal and Fpassive).
Signiﬁcant differences revealed by ANOVAwere analyzed by Newman-Keuls method.
Patients with AS and patients with AR, subgrouped as having moderate or severe di-
astolic dysfunction or normal/mild or moderate/severe systolic dysfunction respec-
tively, were compared for N2BA/N2B isoform expression between subgroups and
with controls bymeans of unpaired t-test for normally distributed values orWilcoxon
rank-sum test for not normally distributed values (N2BA/N2B isoform ratio in AS pa-
tients with severe diastolic dysfunction). Nominal variables were processed by
means of the χ2 test or the Kruskal-Wallis one-way test of variance when appropriate.
Force measurements were averaged from 3 to 4 samples from each heart and this
mean value was taken as a single datum point for the calculation of the overall means.
Pearson's correlation coefﬁcient was used to assess the association between titin iso-
form expression and echocardiographic data and titin isoform expression and force
measurement data. Simple linear regression analysis was used for modeling the rela-
tionship titin isoform ratio (explanatory variable) and RWT or LVEF (scalar depen-
dent variable). A p value b0.05 was considered signiﬁcant for all measurements.
Data were analyzed by SPSS version 15 for Windows (SPSS, Inc., Chicago, IL, USA).
3. Results
3.1. Echocardiography
Table 1 summarizes preoperative echocardiographic characteris-
tics. Quantitative parameters regarding measurements in AR pa-
tients should be viewed with caution and only in the context of the
other signs of severity because of the intrinsic limitations of quanti-
tative measurement. All patients with AS had normal or reduced LV
dimensions and increased LVMI. Moderate LV diastolic dysfunction
occurred in 25 patients (71.4%), severe in 10 (28.6%). All AR patients
had LV dilatation. Eight patients (22.8%) showed preserved LV func-
tion, 14 patients (40%) hadmild LV systolic dysfunction, moderate or
severe LV systolic dysfunction occurred respectively in 8 (22.8%) and
5 patients (14.4%). Increased LVMI was associated to reduced RWT
(eccentric LV hypertrophy) in 11 patients (31.4%). According to the
scheme of LV remodeling based on volume, mass, and geometry, all
AS patients were classiﬁed as having concentric hypertrophy.
Among AR patients, 9 (25.7%) were classiﬁed as having physiologic
hypertrophy, 26 (74.3%) eccentric hypertrophy.
3.2. Titin isoforms expression and ratio
Densitometric analysis of gels revealed that N2B andN2BAbandswere
prominent in all samples and only limited levels of titin degradation
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taken from controls, AS or AR patients. Fig. 1-a-b. Total titin content
(N2BA+N2B+ T2) per unit of tissue was higher by≈7% in AS patients
and lower by≈5% in AR patients compared to controls. However, the
changes did not reached statistical signiﬁcance (p= 0.3 and p= 0.4
respectively).
Mean N2BA/N2B isoform expression were 30 ± 5/70 ± 5 (ratio
0.43 ± 0.02) in controls, 18 ± 5/82 ± 5 (ratio 0.24 ± 0.02) in AS and
35± 5/65 ± 5 (ratio 0.51± 0.04) in AR. There was statistically signiﬁ-
cant difference among groups as determined by one-way ANOVA, (p
b 0.001). The Newman-Keuls post-hoc test conﬁrmed that differences
in N2BA/N2B isoform ratio among each study groupwere all statistically
signiﬁcant.
In AS samples themean expression of the stiffer N2B isoformwas in-
creased at the expense of themore compliant N2BA isoform. In contrast,
in AR samples theN2BA titin isoformwasmore dominant, accompanied
by a down-regulation of N2B titin isoform. Of note, we did not ﬁnd sig-
niﬁcant differences in titin isoform expression between the apex and
mid lateral wall of the LV in the 3 normal donor hearts tested for the
possible regional gradient. The N2BA/N2B distribution in the apex was
30.2/69.8% (ratio 0.43) and in the mid lateral wall was 32.8/67.2 (ratio
0.48) (p= 0.9). The distribution of N2BA/N2B titin isoform ratios ob-
tained from the apex of LV in controls and diseased hearts and speciﬁc
relationship with the degree of diastolic or systolic dysfunction are
depicted in Table 2.
Analyzed by linear regression, N2BA/N2B ratio and RWT were
closely related only in patients with AS (R2 = 0.71, p b 0.001) com-
pared to the modest correlation revealed in that with AR (R2 = 0.43,
p=0,05). Hence, the higher LV concentric hypertrophy is accompanied
by a switching toward the higher expression of the stiffer N2B isoformFig. 1. a) Representative gels of samples from the apex of the left ventricle of patients with ao
compound. Note, the titin T2 degradation products are resolved into one band. The amount o
analysis of N2BA/N2B isoform ratio for correlation to relative wall thickness of the left ventric
of N2BA/N2B isoform ratio for correlation to Left ventricular ejection fraction (LVEF) of the leftwhereas the LV eccentric hypertrophy imply increased level of the
more compliant N2BA isoform no proportionally related. Finally, the
comparative analysis of N2BA/N2B ratio in controls versus patients
with normal/mild LV systolic dysfunction and in controls versus those
with moderate/severe systolic dysfunction revealed that titin isoform
expression was signiﬁcantly deranged irrespectively from LV systolic
function. Table 2. However, at linear regression analysis there was a
close relationship between N2BA/N2B ratio and LVEF (R2 = 0.86, p=
0.004) as the change in titin isoform ratio in AR group was mainly
driven by the severity of the LV systolic function. Fig. 1-c-d.
3.3. Mechanical properties measurements
The average force-pCa relations obtained for controls, AS and AR pa-
tients are shown in Fig. 2-a. At pCa 4.5, force reached a clear plateau.
Therefore, in subsequent experiments, pCa 4.5was assessed as themax-
imal force. Furthermore, force-pCa2+ characteristics of isolated
cardiomyocytes were measured to determinate the pCa50 in all groups.
pCa50, corresponded to the [Ca2+] at which Ftotal-Fpassive reached
50% of the value observed at maximal activation. Accordingly, in subse-
quent experiments, pCa50 was used for measuring submaximal force.
Analyzed by one-way ANOVA, Ftotal at pCa 4.5 was not statistically dif-
ferent among AS (19.8 ± 3.3 kN/m2) and AR (18.8 ± 3.1 kN/m2) and
controls (21.2 ± 2.8 kN/m2) cardiomyocytes (p=0.37). Fig. 2-b. Calcu-
lated pCa50 were similar in controls, AS patients AR patients (5.5 ± 0.4,
5.4 ± 0.3 and 5.3 ± 0.3 kN/m2 respectively, p=0.09).Fig. 2-c. By con-
trast, As compared to controls Fpasive was higher in AS specimens
(6.7 ± 0.2 vs 4.4 ± 0.4 kN/m2, p b 0.001) whereas it was lower in AR
specimens (3.7 ± 0.2 vs 4.4 ± 0.4 kN/m2, p b 0.001). Fig. 2-d. The
Newman-Keuls post-hoc test conﬁrmed that differences in Fpassivertic stenosis (AS), aortic regurgitation (AR) and normal donor heart. T2, titin degradation
f the T2 bands appeared not to vary in controls, AS and AR samples. c) Linear regression
les of patients with aortic stenosis and aortic regurgitation. d) Linear regression analysis
ventricle of patients with aortic regurgitation.
Table 2
Densitometric Analysis of Gels: Titin-isoform Expression.
N2BA/N2B isoform N2BA/ N2B ratio
Controls 30 ± 5/70 ± 5 0.43 ± 0.02
Aortic Stenosis 18 ± 5/82 ± 5 0.24 ± 0.02
Moderate LV diastolic dysfunction 19 ± 4/81 ± 5 0.23 ± 0.02
Severe LV diastolic Dysfunction 15 ± 6/85 ± 5 0.17 ± 0.03
Aortic Regurgitation 35 ± 5/65 ± 5 0.51 ± 0.04
Normal LV systolic function 32 ± 4/68 ± 4 0.47 ± 0.03
Mild LV systolic dysfunction 33 ± 3/67 ± 5 0.49 ± 0.03
Moderate LV systolic dysfunction 34 ± 5/66 ± 5 0.51 ± 0.04
Severe LV systolic dysfunction 37 ± 5/63 ± 5 0.58 ± 0.07
Aortic stenosis vs aortic regurgitations vs controls p b 0.001
Aortic stenosis
Moderate vs severe LV diastolic dysfunction p b 0.001
Moderate LV diastolic dysfunction vs controls p b 0.001
Severe LV diastolic dysfunction vs controls p b 0.001
Aortic regurgitation
Normal/mild vs moderate/severe LV systolic dysfunction p b 0.001
Normal/mild LV systolic dysfunction vs controls p b 0.001
Moderate/severe LV systolic dysfunction vs controls p b 0.001
Comparative evaluation of N2BA/ N2B isoform ratios among groups and within groups
according to LV function.
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correlation, AS patients showed a signiﬁcant relationship between
the higher Fpassive and the lower N2BA/N2B titin isoforms ratio (r=
−0.77, p b 0.001). Interestingly, Fpassive was signiﬁcantly higher inFig. 2. (a) Mean Ftotal-pCa relation for cardiomyocytes of control, aortic stenosis (AS) and aorti
activation). (b) Bare graph display of Ftotal at maximal activation in cardiomyocytes from contr
(c) Bare graph display of PCa50 in cardiomyocytes from controls, AS and ARhearts. Bare graph co
cardiomyocytes from controls, AS and AR hearts. Bare graph compares also Fpassive after in vit
hearts (open circles), 30 heartswith AS (blackﬁlled circles) and 30heartswith AR (grey open ci
the highest Fpassive was registered in patients 1,6,10,14,18, 22 all whom had severe diastolic dAS patientswith severe rather thanwithmoderate LV diastolic dysfunc-
tion (7.1 ± 0.5 vs 6.6. ± 0.6, p=0.004). By contrast, in AR patients, the
lower Fpassive showed only a weak correlation with higher N2BA/N2B
titin isoforms ratio (r= 0.2, p= 0.04). Furthermore, in AR patients
Fpassivewas independent from either the degree of LV systolic dysfunc-
tion (p=0.7) or the presence of severe LV dilatation (p=0.6). Fig. 2-d
shows individual Fpassive in each patients and controls. After PKA, in
controls Fpassive dropped from 4.4 ± 0.4 to 3.4 ± 0.3 kN/m2kN/m2.
The drop in Fpassive was larger in AS patients than in AR patients
(p b 0.001) because Fpassive fell to a similarly lower level in AS patients
(3.5 ± 0.3 kN/m2) and in AR patients (3.3 ± 0.2 kN/m2). Fig. 2-d. Inter-
estingly, Ftotal at maximal activation did not change after PKA treat-
ment in all groups whereas pCa50 fell in all groups but the differences
reached statistical signiﬁcance only AS patients. Fig. 2-b-c. By Pearson's
correlation, the higher Fpassive dropwas strictly relatedwith the higher
titin N2B isoform content (r=−0.88, p b 0.001).
4. Discussion
The present study yielded the following information: compared to
controls (a) the total titin content was tendentially increased in AS
cardiomyocytes and tendentially reduced in AR cardiomyocites al-
though the relative differenced did not reached statistical signiﬁcance;
(b) the N2BA/N2B isoforms ratio was lower in AS patients but was
higher in AR patients; (c) comparedwith controls, at a sarcomere length
of 2.2 μm, Ftotal at maximal [Ca2+] in both AS and AR cardiomyocytes
was comparable as well as submaximal force (pCa50), but the Fpassive
was higher in AS patients and lower in AR patients; (d) afterc regurgitation (AR) groups. pCa (10log[Ca2+]) ranged from 9.0 (relaxing) to 4.5 (maximal
ols, AS and AR hearts. Bare graph compares also Ftotal after in vitro administration of PKA.
mpares also PCa50 after in vitro administration of PKA. d) Bare graph display of Fpassive in
ro administration of PKA. (e) Fpassive in individual cardiomyocytes from 10 normal donor
rcles). Each individual value is themean value obtained from3 to 4 samples analyzed. Note,
ysfunction.
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larger in AS; (e) different titin isoform expressions are consistent with
the systolic/diastolic properties of the LV; (f) results obtained from nor-
mal donor hearts, contributes to a clearer deﬁnition of normal titin iso-
form expression and behavior in human.
The role of titin in the stiffening of cardiac wall has been evaluated
by several authors in mammalian models. Earlier studies established
that titin isoform shift is usually associated to pathological situations
cardiac overload. In a caninemodel of pacing-induced dilated cardiomy-
opathy,Wu reported a titin-isoform shift after fourweeks of stimulation
[8]. More recently, Hamdani showed abnormal calcium sensitivity of
cardiomyocytes and the shift toward the stiffer and less distensible
N2B isoform in dogs with hypertension-induced LV hypertrophy [24].
Consistent with these results, Warren described less expression of
N2BA and greater of N2B titin isoform in hypertensive rat ventricles
[9]. Disease-induced changes in the titin expression have been de-
scribed also in humans with chronic heart diseases. The possible mech-
anisms involved in the disease-induced titin isoform expression is still
unclear, however it has been suggested that systolic and diastolic
heart failure express distinct post-translational changes in the sarco-
meric proteins resulting in altered titin isoform expression and phos-
phorylation. The titin behavior in patients with chronically diseased
aortic valve has been questioned only by a few studies hitherto. As
very little is known about patients with AR, titin composition and its re-
lationshipswith cardiomyocytes contractile function in patientswith AS
has been analyzed only by Falcao-Pires andWilliams [14,15]. However,
they reported contradictory results not only in their patients with AS
(titin isoform ratio increased to 0.61 ± 0.07 and reduced to 0.48 ±
0.03 respectively) but also in their normal controls (0.39 ± 0.05 and
0.66 ± 0.04 respectively). These remarkable discrepancies probably
rely on the different experimental/clinical contexts where titin isoforms
expression was studied: Falcao-Pires analyzed perioperative LV
endomyocardial biopsies resected during cardioplegic arrest whereas
in the Williams's study it is unclear whether patients with coexisting
AR were also included and the time point for biopsy during the AVR
procedures.
As rule, in adults with AS the LV adapts to systolic pressure overload
through a hypertrophic process resulting in increased LVwall thickness
[13,25]. Thus, the inverse relation between systolic wall stress and ejec-
tion fraction is maintained. Until wall stress will be normal, the ejection
fractionwill be preserved. Titin, as themain determinant of passive ten-
sion of the cardiomyocytes, has been reported to be one of themain de-
terminant of the ventricular compliance. Our results support the
hypothesis that the abundance of the stiffer N2B and the reduced ratio
between the N2BA and N2B isoforms in AS are probably the main, al-
though not the only, contributors to the high diastolic stiffness which
inﬂuences the heart ﬁlling. When wall stress normalizes because of hy-
pertrophy, systolic performance also normalizes. Thus, LV ejection per-
formance could remain in the normal range for a long time.
By contrast, in chronic AR, the LV responds to the volume load with
different compensatory mechanisms including an increased end-
diastolic volume and chamber compliance as well as a combination of
eccentric and concentric hypertrophy all of which accommodate the
higher volume without signiﬁcant changes in ﬁlling pressures. The
lower myocardial stiffness and the increased compliance of the LV,
likely due to the prevalence of the more distensible N2BA isoform,
could allow for faster ﬁlling and larger end-diastolic volumes for a
given ﬁlling pressure. This can function as an adaptation mechanism,
as the increase in the LV compliance allows an increase in the
telediastolic volume and, consequently, an increase in cardiac output,
according to the Frank-Starling mechanism. However, this balance can-
not be maintained indeﬁnitely and the transition toward LV deteriora-
tion is progressive. This evolution, due to impairment of Frank-
Starling mechanism, should be probably ascribed to the decreased sen-
sitivity of myoﬁlaments for Ca2+ due to the lower development of pas-
sive tension in the presence of increased N2BA isoform [11].In this study, Fpassive in control subjects was 35% lower than in AS
patients whereas it was 16% higher in AR patients. Different Fpassive
of cardiomyocytes could be ascribed to impaired calcium metabolism
or to modiﬁed myoﬁlament or cytoskeletal proteins. Taking into ac-
count that altered calcium metabolism must be excluded in our
cardiomyocytes due to disrupted integrity of sarcolemmal and sarco-
plasmic membranes, the differences in Fpassive could be attributed to
altered expression or phosphorylation of cytoskeletal proteins. As-
sumed that titin has phosphorylation sites, in agreement with previous
studies, we found that its phosphorylation by PKA lowered Fpassive in
isolated cardiomyocytes, especially in case of overexpression of the
stiff isoform of titin (N2B).[14,23,26] Furthermore, the fall in Fpassive
after PKA was larger in AS patients than in AR patients. Fig. 2-c. This
larger fall after PKAwas consistent with the larger N2B isoform expres-
sion in cardiomyocytes of AS patients. Given that the increased expres-
sion of the N2B isoform is associated with increased titin rigidity, this
rigidity can be reduced by the phosphorylation of titin by PKA to levels
very similar to those found in controls. The decrease in Fpassive after
PKA treatment was directly proportional to the initial rigidity of the
cardiomyocytes, which is in agreement with the idea that the increase
in cardiac rigidity is directly related not only to alterations in the relative
expression of the isoforms, but also to the state of hypophosphorylation
of the rigid isoform of titin. Accordingly, due to the lower rigidity of the
cardiomyocytes of patients with AR, the same treatment with PKA did
not result in signiﬁcant Fpassive. These ﬁndings are particularly rele-
vant, as they can also be the target of therapeutic intervention in pa-
tients with AS or AR to improve the diastolic ﬁlling or the systolic
function of the ventricles.5. Limitations
The statistical power of the studymay be hampered by the small size
of the AS and AR populations. All biopsy samples were derived from the
apex which could have overlooked the possible myocardial tissue het-
erogeneity. However, consistent with previous studies, we failed to de-
tect a signiﬁcant heterogeneity in our samples obtained from the apex
or the mid-lateral wall (only a negligible difference of about 5–7% has
been found). Themain strength of this study consists in the high homo-
geneity of each group carefully selected and the abundance of each
specimen. Furthermore, contrarily to previous study which evaluated
biopsy samples obtained from transplant recipients or from the right
ventricle of patients with clinical suspicion of cardiomyopathy, all our
biopsy consisted of full thickness specimens taken from the apex of
the left ventricle. Finally, the mean age of the donor hearts was signiﬁ-
cantly lower compared to AS or AR patients, which could be a not neg-
ligible limitation assuming that titin based stiffness might also change
with the age. Nonetheless, we hypothesized that our control samples
were quite indicative as it may be almost impossible to collect these bi-
opsy samples from donors of similar age than diseased patients.6. Conclusions
Titin isoform expression differs in AS and AR as adaptive response to
different pathophysiologic scenarios. LV myocardium in AS and AR dif-
fers in both titin isoform expression and function.
suggesting AS and AR to be associated with distinct cardiomyocyte
abnormalities. Co-expressing isoforms at varying ratios results in mod-
ulation of the passive mechanical behavior of the LV at different degree
of dysfunction and allows for compensative adjustment of the diastolic/
systolic properties of the myocardium.Conﬂict of interest
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144 V. Mannacio et al. / International Journal of Cardiology 259 (2018) 138–144Funding sources
None.
References
[1] S. Heina, S. Kostinb, A. Helingb, Y. Maenob, J. Schaperb, The role of the cytoskeleton
in heart failure, Cardiovasc. Res. 45 (2000) 273–278.
[2] A.M. Katz, M.R. Zile, Newmolecular mechanism in diastolic heart failure, Circulation
113 (2006) 1922–1925.
[3] B. Russell, G.H.G. Motlagh, W.W. Ashley, Form follows function: how muscle shape
is regulated by work, J. Appl. Physiol. 88 (2000) 1127–1132.
[4] O. Cazorla, A. Freiburg, M. Helmes, et al., Differential expression of cardiac titin iso-
forms and modulation of cellular stiffness, Circ. Res. 86 (2000) 59–67.
[5] M.M. LeWinter, H. Granzier, Cardiac Titin: a multifunctional giant, Circulation 121
(2010) 2137–2145.
[6] M.M. LeWinter, Y. Wu, S. Labeit, H. Granzier, Cardiac titin: structure, functions and
role in disease, Clin. Chim. Acta 375 (2007) 1–9.
[7] R. Castro-Ferreira, R. Fontes-Carvalho, I. Falcão-Pires, A.F. Leite-Moreira, The role of
titin in the modulation of cardiac function and its pathophysiological implications,
Arq. Bras. Cardiol. 96 (2011) 332–339.
[8] Y. Wu, S.P. Bell, K. Trombitas, et al., Changes in titin isoform expression in pacing-
induced cardiac failure give rise to increased passive muscle stiffness, Circulation
106 (2002) 1384–1389.
[9] C.M. Warren, M.C. Jordan, K.P. Roos, P.R. Krzesinski, M.L. Greaser, Titin isoform ex-
pression in normal and hypertensive myocardium, Cardiovasc. Res. 59 (2003)
86–94.
[10] C. Neagoe, M. Kulke, F. del Monte, et al., Titin isoform switch in ischemic human
heart disease, Circulation 106 (2002) 1333–1341.
[11] S.F. Nagueh, G. Shah, Y. Wu, et al., Altered titin expression myocardial stiffness, and
left ventricular function in patients with dilated cardiomyopathy, Circulation 110
(2004) 155–162.
[12] N. Fukuda, H.L. Granzier, Titin/connectin-based modulation of the frank-Starling
mechanism of the heart, J. Muscle Res. Cell Motil. 26 (2005) 319–323.[13] V. Mannacio, E. Guadagno, L. Mannacio, et al., Comparison of left ventricular myo-
cardial structure and function in patients with aortic stenosis and those with pure
aortic regurgitation, Cardiology 132 (2015) 111–118.
[14] I. Falcão-Pires, N. Hamdani, A. Borbély, et al., Diabetes mellitus worsens diastolic left
ventricular dysfunction in aortic stenosis through altered myocardial structure and
cardiomyocyte stiffness, Circulation 124 (2011) 1151–1159.
[15] L. Williams, N. Howell, D. Pagano, et al., Titin isoform expression in aortic stenosis,
Clin. Sci. 117 (2009) 237–242.
[16] R.O. Bonow, B.A. Carabello, C. Kanu, et al., ACC/AHA 2006 guidelines for the manage-
ment of patients with valvular heart disease, Circulation 114 (2006) e84–231.
[17] V.A. Mannacio, M. Imbriaco, S. Iesu, A.L. Giordano, L. Di Tommaso, C. Vosa, 64-slice
multidetector computed tomographic evaluation of arterial conduit patency after
off-pump coronary artery bypass grafting, Tex. Heart Inst. J. 36 (2009) 409–415.
[18] H. Baumgartner, J. Hung, J. Bermejo, et al., Echocardiographic assessment of valve
stenosis: EAE/ASE recommendations for clinical practice, Eur. J. Echocardiogr. 10
(2009) 1–25.
[19] W.A. Zoghbi, M. Enriquez-Sarano, E. Foster, et al., Recommendations for evaluation
of the severity of native valvular regurgitation with two-dimensional and Doppler
echocardiography, J. Am. Soc. Echocardiogr. 16 (2003) 777–802.
[20] R.M. Lang, M. Bierig, R.B. Devereux, et al., Recommendations for chamber quantiﬁca-
tion, Eur. J. Echocardiogr. 7 (2006) 79–108.
[21] W.H. Gaasch, M.R. Zile, Left ventricular structural remodeling in health and disease,
J. Am. Coll. Cardiol. 58 (2011) 1733–1740.
[22] S.F. Nagueh, C.P. Appleton, T.C. Gillebert, et al., Recommendations for the evaluation
of left ventricular diastolic function by echocardiography, J. Am. Soc. Echocardiogr.
22 (2009) 107–133.
[23] A. Borbély, J. van der Velden, Z. Papp, et al., Cardiomyocyte stiffness in diastolic heart
failure, Circulation 15 (11) (2005) 774–781.
[24] N. Hamdani, K.G. Bishu, M. von Frieling-Salewsky, M.M. Redﬁeld, W.A. Linke, De-
ranged myoﬁlament phosphorylation and function in experimental heart failure
with preserved ejection fraction, Cardiovasc. Res. 97 (2013) 464–471.
[25] A.N. Rassi, P. Pibarot, S. Elmariah, Left ventricular remodelling in aortic stenosis, Can.
J. Cardiol. 30 (2014) 1004–1111.
[26] A. Borbély, I. Falcao-Pires, L. van Heerebeek, et al., Hypophosphorylation of the stiff
N2B titin isoform raises cardiomyocyte resting tension in failing human myocar-
dium, Circ. Res. 104 (6) (2009) 780.
